about
Increased expression of AP2 and Sp1 transcription factors in human thyroid tumors: a role in NIS expression regulation?Recent advances in the molecular genetics of type 2 diabetes mellitusTranscriptional activity of the murine retinol-binding protein gene is regulated by a multiprotein complex containing HMGA1, p54 nrb/NonO, protein-associated splicing factor (PSF) and steroidogenic factor 1 (SF1)/liver receptor homologue 1 (LRH-1)The HMGA1-IGF-I/IGFBP system: a novel pathway for modulating glucose uptake.A novel mechanism of post-translational modulation of HMGA functions by the histone chaperone nucleophosmin.The Association between HMGA1 rs146052672 Variant and Type 2 Diabetes: A Transethnic Meta-Analysis.Insulin resistance and cancer risk: an overview of the pathogenetic mechanisms.Functional relationship between high mobility group A1 (HMGA1) protein and insulin-like growth factor-binding protein 3 (IGFBP-3) in human chondrocytesEarly effects of a hypocaloric, Mediterranean diet on laboratory parameters in obese individualsRegulatory functions of insulin-like growth factor binding proteins in osteoarthritis.High-mobility group A1 protein: a new coregulator of peroxisome proliferator-activated receptor-γ-mediated transrepression in the vasculature.The correct renal function evaluation in patients with thyroid dysfunction.Impact of seasonality on gestational diabetes mellitus.A polymorphism of HMGA1 protects against proliferative diabetic retinopathy by impairing HMGA1-induced VEGFA expression.Gestational diabetes mellitus: an updated overview.Pseudogene-mediated posttranscriptional silencing of HMGA1 can result in insulin resistance and type 2 diabetes.Cooperation between HMGA1 and HIF-1 Contributes to Hypoxia-Induced VEGF and Visfatin Gene Expression in 3T3-L1 AdipocytesNew target genes for the peroxisome proliferator-activated receptor-γ (PPARγ) antitumour activity: Perspectives from the insulin receptorEditorial: "Linking Hypoxia to Obesity".Comment on: Marquez et al. Low-frequency variants in HMGA1 are not associated with type 2 diabetes risk. Diabetes 2012;61:524-530Evidence that an HMGA1 gene variant associates with type 2 diabetes, body mass index, and high-density lipoprotein cholesterol in a Hispanic-American population.Lack of the architectural factor HMGA1 causes insulin resistance and diabetes in humans and mice.HMGA1 is a novel transcriptional regulator of the FoxO1 gene.Type 2 Diabetes Mellitus and Cardiovascular Disease: Genetic and Epigenetic Links.A new predictive tool for the early risk assessment of gestational diabetes mellitus.Insulin and osteocalcin: further evidence for a mutual cross-talk.Postpartum glucose intolerance: an updated overview.Correction to: Insulin and osteocalcin: further evidence for a mutual cross-talk.Comment on Li et al. HMGA1: A novel predisposing gene for acute myocardial infarction.Add-On Treatment with Liraglutide Improves Glycemic Control in Patients with Type 2 Diabetes on Metformin Therapy.Prevalence and predictors of postpartum glucose intolerance in Italian women with gestational diabetes mellitus.HMGA1 is a novel candidate gene for myocardial infarction susceptibility.High Mobility Group A (HMGA) proteins: Molecular instigators of breast cancer onset and progression.Secretome Analysis of Hypoxia-Induced 3T3-L1 Adipocytes Uncovers Novel Proteins Potentially Involved in Obesity.Cross-talk among HMGA1 and FoxO1 in control of nuclear insulin signaling.Effects of Oleacein on High-Fat Diet-Dependent Steatosis, Weight Gain, and Insulin Resistance in Mice.Indole and 2,4-Thiazolidinedione conjugates as potential anticancer modulatorsInfluence of Chitosan Glutamate on the in vivo Intranasal Absorption of Rokitamycin from MicrospheresEditorial: Hormone Receptors and Breast CancerFirst Trimester Combined Test (FTCT) as a Predictor of Gestational Diabetes Mellitus
P50
Q24794449-7303CB0F-427F-4732-B5BA-B97907605B97Q26996335-2CF09402-F262-4E1E-932C-B417F9BBE8ACQ28510034-43AC6D90-59E4-41F9-8E3E-02BD958BE08DQ33636295-E710B101-67FD-4BD6-B00F-5160D0352A26Q35119536-336A86F4-07DA-46DB-B844-75A60C79DF06Q35752520-6C353AD0-B836-4B3E-95FC-0BB226CB4AF1Q36023488-D8D70931-6A3F-43A0-BA1F-916C5C6DC9F2Q36633155-35C114A8-74B5-4C7D-9AD0-6E98FB4DEE0CQ37651059-430CB783-23BA-4BB4-AE5F-C4F0CA6BB2AFQ37888841-290479B3-0F84-4161-A7C6-BD6DCBC76C21Q38329149-8CEE3C5B-675C-4E19-80F9-A7AB4A6AFA5EQ38618924-CA5B9758-98D4-4B1F-AA10-0E54E6B57964Q38635284-4380CA14-8614-4117-B29C-D38FB2EE066DQ39089813-946B1C77-A8CD-4E16-9CB3-D5509DAFE4FFQ39173703-07FD7722-EB9B-4D20-B5E5-5170052EF62FQ39639920-8BCE1968-75E8-44C7-B3AE-7DFCB3E11D37Q42085884-E0C7C68B-AB4E-4FB4-8BAC-85A55E84EB73Q42167608-DF161884-598D-47ED-A6F4-92F97B9CE59FQ42320501-21A6E652-B3B7-4F73-BA16-F4726D30954DQ42536336-804CA28A-4519-40EC-B720-A700D4A9E134Q43479487-F2221EC8-DC9B-4433-BE9C-EC43690F9176Q46517052-1B42B3FA-8E61-4032-83F4-9AF8DB04F5EDQ47625691-CA80053E-86C3-469B-B5BF-2738A9DE33FBQ47701069-1DBB52B0-3093-4790-AC63-7C53CEB49782Q47777344-B14D8283-D537-4050-9FC9-1F829409B4A0Q48135687-D7AD9620-923B-40CC-B276-C3B9E366480CQ48238530-BDA93028-98E7-41E8-B900-7817FB047808Q48351050-866352C6-DC20-4D58-B351-5E62DCE947E3Q49899975-19561696-2DFD-4183-AAE1-72B0660E10C2Q51036819-75F1310B-1CA7-46FF-9CD6-C5B883D6EC8BQ51320838-8FF30D20-8CC2-4964-BF7D-2A75C67D8292Q51329731-D9C9BB97-E372-4F91-90E7-68E43C04EFBFQ52666624-CDB2060B-DA1D-4BF6-ACEB-EA824C6B2040Q52691978-3DA58894-4B4F-446C-84D4-7869079E6DD9Q55084839-16A38B5A-7E23-4A56-A13C-232C5322F855Q55231905-B1AB34DE-9D56-4198-8EB2-2C59457F2728Q58795617-C96EF62B-E2A1-4695-B627-DBF0A96DBF82Q63433730-3FE41B0B-55C1-4C1E-9E40-0ACAF65E40A9Q64084404-59A6057C-1BC1-4ADC-9944-E76D40A052A6Q90381986-D308F71C-B8BD-4374-8534-69C0D47878F1
P50
description
researcher ORCID ID = 0000-0003-1533-8779
@en
name
Antonio Brunetti
@ast
Antonio Brunetti
@en
Antonio Brunetti
@es
Antonio Brunetti
@nl
type
label
Antonio Brunetti
@ast
Antonio Brunetti
@en
Antonio Brunetti
@es
Antonio Brunetti
@nl
altLabel
A. Brunetti, MD, PhD
@en
prefLabel
Antonio Brunetti
@ast
Antonio Brunetti
@en
Antonio Brunetti
@es
Antonio Brunetti
@nl
P106
P21
P2798
P31
P496
0000-0003-1533-8779